Video

Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator

At AAN 2017, Peter Goadsby, M.B., B.S., Director of the NIHR- Wellcome Trust King’s Clinical Research, London, Professor of Neurology, University of California at San Francisco, discussed the recent FDA approval of the gammaCore non-invasive vagal nerve stimulator. Goadsby believed this would have a significant impact on patients with cluster headache. It’s an acute treatment; so it’s a way of treating the attacks that come.


Related Videos
Developing Risk Assessment Tools for Viruses in School
Rahul Aggarwal, MD | Credit: LinkedIn
Sorana Segal-Maurer, MD, an expert on HIV
Brendon Neuen, MBBS, PhD | Credit: X.com
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Shauna Applin, ARNP, an expert on HIV
© 2024 MJH Life Sciences

All rights reserved.